The global pet gut microbiome testing market is experiencing notable expansion, driven by growing awareness among pet owners about the importance of digestive health in overall animal wellbeing, and rising prevalence of gastrointestinal issues in companion animals. In 2025, the market was valued at roughly USD 51 million and is expected to reach around USD 150 million by 2032, reflecting a significant compound annual growth rate over the forecast period.
This market growth is underpinned by several key factors. First, the humanization of pets — with owners increasingly treating pets as family members — is motivating greater investment in advanced healthcare services beyond basic veterinary care. Pet owners’ willingness to spend on preventive and diagnostic solutions, including gut microbiome assessment, has surged, particularly in developed regions where disposable incomes are higher.
Technological advancements are also crucial. Innovations in sequencing, bioinformatics, and testing processes have made microbiome tests more accurate, accessible, and user-friendly. At-home kits that allow owners to collect fecal samples with instructions and send them for detailed microbial analysis have become common, boosting market adoption. Simultaneously, laboratory-based services offered through clinics and specialized labs continue to grow, especially where professional interpretation of results can guide diagnosis or treatment plans.
The role of gut microbiota in disease prevention and management is increasingly recognized by veterinarians. Testing is no longer limited to diagnosis of acute gastrointestinal problems but is also used for nutritional assessment and tailored wellness strategies. This shift towards preventive and personalized care is expanding the addressable market across species.
Regional dynamics vary: North America currently holds the largest share due to high pet ownership and advanced veterinary infrastructure. Europe follows closely with robust demand for premium pet healthcare. The Asia Pacific region is slated to witness the fastest growth driven by rising pet adoption and improving economic conditions. Latin America and the Middle East & Africa are projected to grow steadily as pet care standards improve.
Despite strong growth prospects, the market faces some challenges, such as the relatively high cost of comprehensive microbiome analysis services and the ongoing need for standardization in testing methodologies. Addressing these will be critical to sustaining long-term expansion.
